Michael Denis Coffee Net Worth

What's Michael Coffee's mailing address?

Michael's mailing address filed with the SEC is 4350 LA JOLLA VILLAGE DRIVE, SUITE 950, , SAN DIEGO, CA, 92122.

Insiders trading at Medicinova Inc

Over the last 18 years, insiders at Medicinova Inc have traded over $200,908 worth of Medicinova Inc stock and bought 459,744 units worth $1,581,779 . The most active insiders traders include Jeff Himawan, Masatsune Okajima и Yuichi Iwaki. On average, Medicinova Inc executives and independent directors trade stock every 95 days with the average trade being worth of $74,094. The most recent stock trade was executed by Hideki Nagao on 28 November 2022, trading 6,754 units of MNOV stock currently worth $15,197.

What does Medicinova Inc do?

pharmaceutical preparations

Medicinova Inc executives and stock owners

Medicinova Inc executives and other stock owners filed with the SEC include:

• Yuichi Iwaki,
  President, Chief Executive Officer, Director
• Kazuko Matsuda,
  Chief Medical Officer, Director
• Geoffrey O'brien,
  Vice President
• Dr. Yuichi Iwaki M.D., Ph.D.,
  Co-Founder, Pres, CEO & Exec. Director
• Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.,
  Chief Medical Officer & Director
• Hideki Nagao,
  Independent Director
• Carolyn Beaver,
  Director
• Edward Stepanow,
  Chief Financial Officer
• Jeffrey Himawan,
  Independent Chairman of the Board
• John O'Neil CPA,
  Controller
• Dr. David H. Crean Ph.D.,
  Chief Bus. Officer
• Dr. Federico Gaeta Ph.D.,
  Chief Scientific Officer
• Douglas G Paulin CPA, CPA,
  Chief Financial Officer
• Yutaka Kobayashi,
  Director
• Yoshio Ishizaka,
  Director
• Masatsune Okajima,
  VP and Head of Japanese Office
• Federico C.A. Gaeta,
  Chief Scientific Officer
• Tatsuo Izumi,
  Director
• Den Boom Esther Van,
  Chief Financial Officer
• Jeff Himawan,
  Director
• John K A Prendergast,
  Director
• Hiroaki Shigeta,
  Director
• Kirk William Johnson,
  Chief Scientific Officer
• Arlene Morris,
  Director
• Michael Denis Coffee,
  Chief Business Officer
• David D O'toole,
  Director
• Alan W Dunton,
  Director
• Shintaro Asako,
  VP and Chief Financial Officer
• Richard E Sr Gammans,
  Chief Development Officer
• Daniel Vapnek,
  Director
• Kenneth W Locke,
  Chief Scientific Officer
• Michael E Kalafer,
  Chief Medical Officer
• Nicole Lemerond,
  Director